Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer

SIMPLE SUMMARY: Metastatic castration-resistant prostate cancer (mCRPC) is the most aggressive and deadly form of prostate cancer. As a bone-predominant metastatic disease, liquid biopsy-based biomarkers have advantages in monitoring cancer dynamics. Previous studies have demonstrated the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chun, Zhang, Zhenchao, Chong, Weelic, Luo, Rui, Myers, Ronald E., Gu, Jian, Lin, Jianqing, Wei, Qiang, Li, Bingshan, Rebbeck, Timothy R., Lu-Yao, Grace, Kelly, William K., Yang, Hushan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828213/
https://www.ncbi.nlm.nih.gov/pubmed/33450815
http://dx.doi.org/10.3390/cancers13020268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828213/
https://www.ncbi.nlm.nih.gov/pubmed/33450815
http://dx.doi.org/10.3390/cancers13020268

Ejemplares similares